Pharmaceutical giant AstraZeneca is facing a class-action lawsuit over allegations that its Covid-19 vaccine has caused deaths and serious injuries in numerous cases. AstraZeneca, in collaboration with researchers from the University of Oxford, developed and manufactured the vaccine known as Covishield. In recent court documents, AstraZeneca admitted for the first time that the vaccine can potentially cause a rare side effect known as Vaccine-Induced Thrombotic Thrombocytopenia (TTS). The admission follows concerns raised by health experts regarding the safety of the vaccine.

What Is Covishield?

The Covishield Covid-19 vaccine, developed by AstraZeneca in partnership with the University of Oxford, has been widely used in various countries as part of their vaccination efforts. However, recent reports have questioned the vaccine’s safety after AstraZeneca acknowledged that it can lead to rare side effects, including TTS. Covishield has been administered to millions of people worldwide, and the potential risks associated with the vaccine have prompted legal action and further investigations.

Covishield’s Controversial Side Effects

• According to court documents, AstraZeneca has admitted that its Covid-19 vaccine can cause rare side effects.
• The rare side effect called Vaccine-Induced Thrombotic Thrombocytopenia (TTS) has been a cause for concern.
• Health experts have raised questions about the safety of the vaccine following AstraZeneca’s admission.
• A class-action lawsuit has been filed against AstraZeneca over claims of deaths and serious injuries caused by the vaccine.
• The parents of a woman who died after receiving the Covishield vaccine are considering legal action against Serum Institute of India, which manufactured the vaccine.

Might interest you:

Udinese Climbs Serie A Table with Win Over Lecce

Barcelona Battles Arsenal in Zubimendi Transfer Saga

AI Power Play: Microsoft & Amazon Challenge OpenAI Dominance

“AstraZeneca admits its Covishield vaccine can cause rare side-effects,” said a lawyer representing the aggrieved parties.

The acknowledgment by AstraZeneca of potential side effects associated with the Covid-19 vaccine has sparked concerns among vaccine recipients and health experts. While the occurrence of TTS is rare, the seriousness of the side effect cannot be overlooked. Consequently, legal proceedings are being initiated, seeking compensation for those affected. The Serum Institute of India, responsible for the manufacturing of the Covishield vaccine, may also face legal action. As more information emerges, the case against AstraZeneca and its Covishield vaccine continues to unfold, necessitating a thorough examination of all the evidence.